D. T. Shirley, S. N. Moonah, and K. L. Kotloff, Burden of disease from cryptosporidiosis, Curr. Opin. Infect. Dis, vol.25, pp.555-563, 2012.

D. L. Liu, S. Oza, D. Hogan, Y. Chu, J. Perin et al., Global, regional, and national causes of under-5 mortality in 2000-15: An updated systematic analysis with implications for the Sustainable Development Goals, Lancet, vol.388, pp.3027-3035, 2016.

K. L. Kotloff, J. P. Nataro, W. C. Blackwelder, D. Nasrin, T. H. Farag et al., Burden and aetiology of diarrhoeal disease in infants and young, vol.382, pp.209-222, 2013.

J. A. Platts-mills, S. Babji, L. Bodhidatta, J. Gratz, R. Haque et al.,

, Lancet Glob. Health, vol.3, pp.564-575, 2015.

, WHO report, WHO | World health report Report, 2017.

B. Amadi, M. Mwiya, J. Musuku, A. Watuka, S. Sianongo et al., Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: A randomised controlled trial, Lancet, vol.360, pp.1375-1380, 2002.

B. Amadi, M. Mwiya, S. Sianongo, L. Payne, A. Watuka et al., High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: A randomised controlled trial, BMC Infect. Dis, vol.9, p.195, 2009.

W. Checkley, A. C. White, D. Jaganath, M. J. Arrowood, R. M. Chalmers et al., A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium, vol.15, pp.85-94, 2015.

C. T. Liu, J. W. Tomsho, and S. J. Benkovic, The unique chemistry of benzoxaboroles: Current and emerging applications in biotechnology and therapeutic treatments, Bioorg. Med. Chem, vol.22, pp.4462-4473, 2014.

A. Palencia, A. Bougdour, M. Brenier-pinchart, B. Touquet, R. Bertini et al., Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis, vol.9, pp.385-394, 2017.

E. Sonoiki, C. L. Ng, M. C. Lee, D. Guo, Y. Zhang et al., A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue, vol.8, p.14574, 2017.

C. R. Mandel, S. Kaneko, H. Zhang, D. Gebauer, V. Vethantham et al., Polyadenylation factor CPSF-73 is the pre-mRNA 3?-end-processing endonuclease, Nature, vol.444, pp.953-956, 2006.

K. Ryan, O. Calvo, and J. L. Manley, Evidence that polyadenylation factor CPSF-73 is the mRNA 3? processing endonuclease, RNA, vol.10, pp.565-573, 2004.

D. Begolo, I. M. Vincent, F. Giordani, I. Pöhner, M. J. Witty et al., The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing, PLOS Pathog, vol.14, p.1007315, 2018.

R. J. Wall, E. Rico, I. Lukac, F. Zuccotto, S. Elg et al., Clinical and veterinary trypanocidal benzoxaboroles target CPSF3, Proc. Natl. Acad. Sci. U.S.A, vol.115, pp.9616-9621, 2018.

U. H. Manjunatha, S. Vinayak, J. A. Zambriski, A. T. Chao, T. Sy et al., A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis, Nature, vol.546, pp.376-380, 2017.

C. W. Mcnamara, M. C. Lee, C. S. Lim, S. H. Lim, J. Roland et al., Nature, vol.504, pp.248-253, 2013.

S. L. Arnold, R. Choi, M. A. Hulverson, D. A. Schaefer, S. Vinayak et al., Van Voorhis, Necessity of bumped kinase inhibitor gastrointestinal exposure in treating Cryptosporidium infection, J. Infect. Dis, vol.216, pp.55-63, 2017.

M. F. Mojica, R. A. Bonomo, and W. Fast, B1-Metallo-b-Lactamases: Where do we stand?, Curr. Drug Targets, vol.17, pp.1029-1050, 2016.

J. A. Hunt and C. A. Fierke, Selection of carbonic anhydrase variants displayed on phage. Aromatic residues in zinc binding site enhance metal affinity and equilibration kinetics, J. Biol. Chem, vol.272, pp.20364-20372, 1997.

R. T. Jacobs, B. Nare, S. A. Wring, M. D. Orr, D. Chen et al., SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis, PLOS Negl. Trop. Dis, vol.5, p.1151, 2011.

R. T. Jacobs, J. J. Plattner, B. Nare, S. A. Wring, D. Chen et al., Benzoxaboroles: A new class of potential drugs for human African trypanosomiasis, Future Med. Chem, vol.3, pp.1259-1278, 2011.

A. Casañal, A. Kumar, C. H. Hill, A. D. Easter, P. Emsley et al., Architecture of eukaryotic mRNA 3?-end processing machinery, Science, vol.358, pp.1056-1059, 2017.

M. Clerici, M. Faini, R. Aebersold, and M. Jinek, Structural insights into the assembly and polyA signal recognition mechanism of the human CPSF complex, vol.6, p.33111, 2017.

M. Clerici, M. Faini, L. M. Muckenfuss, R. Aebersold, and M. Jinek, Structural basis of AAUAAA polyadenylation signal recognition by the human CPSF complex, Nat. Struct. Mol. Biol, vol.25, pp.135-138, 2018.

Y. Sun, Y. Zhang, K. Hamilton, J. L. Manley, Y. Shi et al., Molecular basis for the recognition of the human AAUAAA polyadenylation signal, Proc. Natl. Acad. Sci. U.S.A, vol.115, pp.1419-1428, 2018.

A. Palencia, R. Liu, M. Lukarska, J. Gut, A. Bougdour et al., Cryptosporidium and Toxoplasma parasites are inhibited by a benzoxaborole targeting leucyl-tRNA synthetase, Antimicrob. Agents Chemother, vol.60, pp.5817-5827, 2016.

C. D. Huston, T. Spangenberg, J. Burrows, P. Willis, T. N. Wells et al., A proposed target product profile and developmental cascade for new cryptosporidiosis treatments, PLOS Negl. Trop. Dis, vol.9, p.3987, 2015.

U. H. Manjunatha, A. T. Chao, F. J. Leong, and T. T. Diagana, Cryptosporidiosis drug discovery: Opportunities and challenges, ACS Infect. Dis, vol.2, pp.530-537, 2016.

S. Vinayak, M. C. Pawlowic, A. Sateriale, C. F. Brooks, C. J. Studstill et al., Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum, Nature, vol.523, pp.477-480, 2015.

G. Wilke, L. J. Funkhouser-jones, Y. Wang, S. Ravindran, Q. Wang et al., A stem-cell-derived platform enables complete Cryptosporidium development in vitro and genetic tractability, Cell Host Microbe, vol.26, pp.123-134, 2019.

S. Lacroix-lamandé, R. Mancassola, M. Naciri, and F. Laurent, Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection, Infect. Immun, vol.70, pp.2090-2099, 2002.

M. Barrier, S. Lacroix-lamandé, R. Mancassola, G. Auray, N. Bernardet et al., Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice, J. Infect. Dis, vol.193, pp.1400-1407, 2006.

S. Lacroix, R. Mancassola, M. Naciri, and F. Laurent, Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: Role of tumor necrosis factor alpha in protection, Infect. Immun, vol.69, pp.1635-1642, 2001.

N. Dimasi, D. Flot, F. Dupeux, and J. A. Márquez, Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun, vol.63, pp.204-208, 2007.

U. Zander, G. Hoffmann, I. Cornaciu, J. Marquette, G. Papp et al., Automated harvesting and processing of protein crystals through laser photoablation, Acta Crystallogr. D Struct. Biol, vol.72, pp.454-466, 2016.

P. Emsley and K. Cowtan, Coot: Model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr, vol.60, pp.2126-2132, 2004.

G. N. Murshudov, A. A. Vagin, and E. J. Dodson, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D Biol. Crystallogr, vol.53, pp.240-255, 1997.

K. Arnold, L. Bordoli, J. Kopp, and T. Schwede, The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling, Bioinformatics, vol.22, pp.195-201, 2006.

, This article cites 38 articles, 9 of which you can access for free